Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/19/25 19:40 | 8/18/25 | DAWN | Health | Drug | Pharmaceutical Preparations | York Charles N II | CA | O | COO,CFO | 5 | S.d | -178 | 9.90 | 0 | -18 | 278 | D | |||||||||||||||
8/19/25 19:38 | 8/18/25 | DAWN | Health | Drug | Pharmaceutical Preparations | Dubow Adam | CA | O | GC,Secre | 5 | S.d | -200 | 10.05 | 0 | -20 | 55 | D | |||||||||||||||
8/19/25 19:37 | 8/18/25 | DAWN | Health | Drug | Pharmaceutical Preparations | Bender Jeremy | CA | DO | CEO | 5 | S.d | -629 | 9.94 | 0 | -63 | 1,770 | D | |||||||||||||||
8/19/25 19:36 | 8/18/25 | DAWN | Health | Drug | Pharmaceutical Preparations | Merendino Lauren | CA | O | Chief Co | 2 | S.d | -50 | 6.51 | 0 | -8 | 42 | D | |||||||||||||||
12/12/24 16:06 | 12/10/24 | DAWN | Health | Drug | Pharmaceutical Preparations | Blackman Samuel C. | CA | O | HEAD OF | 9 | S.dm | -2,230 | 14.44 | 0 | -154 | 2,141 | D | |||||||||||||||
6/21/24 19:17 | 6/21/24 | DAWN | Health | Drug | Pharmaceutical Preparations | Ramasastry Saira | CA | D | 1 | S | -132 | 13.19 | 0 | -10 | 40 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |